Insulet (NASDAQ: PODD)
Insulet Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Insulet Company Info
Insulet makes the leading wearable, tubeless insulin pump for diabetics.
News & Analysis
Why Shares of Insulet Dropped This Week
Positive news regarding diabetes therapy Ozempic worried investors.
Why Insulet Stock Is Sinking Today
Comments from Insulet's CEO at a major healthcare conference rattled investors.
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks?
The S&P 500 had a rare decline last month.
Why Insulet Stock Rocked the Market Today
The company's leader signals a giant vote of confidence in its future.
3 Growth Stocks That Have Delivered 10X Returns Over the Past Decade
Are these stocks still good buys today?
2 Best Medical Device Stocks for 2023
Insulet and Conmed ought to be medtech's shining stars in 2023.
Why Insulet Stock Is Skyrocketing Today
Investors are cheering the company's strong Q3 results.
Why Insulet Stock Is Soaring This Week
The company is reportedly in discussions with Dexcom about a potential merger.
Valuation
Earnings Transcripts
Insulet Corporation (PODD) Q3 2021 Earnings Call Transcript
PODD earnings call for the period ending September 30, 2021.
Insulet Corporation (PODD) Q2 2021 Earnings Call Transcript
PODD earnings call for the period ending June 30, 2021.
Insulet Corp (PODD) Q1 2021 Earnings Call Transcript
PODD earnings call for the period ending March 31, 2021.
Insulet Corp (PODD) Q4 2020 Earnings Call Transcript
PODD earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.